Table 1.
Parameters | All cases (n = 82) | KCNMB2-AS1 expression | P value | |
---|---|---|---|---|
Low (n = 41) | High (n = 41) | |||
Age (years) | ||||
≤45 | 38 | 18 | 20 | 0.658 |
>45 | 44 | 23 | 21 | |
Histology | ||||
Squamous | 45 | 22 | 23 | 0.824 |
Adenocarcinoma | 37 | 19 | 18 | |
Tumor size | ||||
≤4 cm | 50 | 30 | 20 | 0.024 |
>4 cm | 32 | 11 | 21 | |
International Federation of Gynecology and Obstetrics stage | ||||
I and II | 60 | 35 | 25 | 0.013 |
III | 22 | 6 | 16 | |
Lymph node metastasis | ||||
Negative | 52 | 31 | 21 | 0.022 |
Positive | 30 | 10 | 20 | |
Tumor differentiation | ||||
Well/moderate | 51 | 29 | 22 | 0.111 |
Poor | 31 | 12 | 19 | |
HPV infection | ||||
Negative | 65 | 37 | 28 | 0.014 |
Positive | 17 | 4 | 13 | |
miR-130b-5p | ||||
Low | 41 | 15 | 26 | 0.015 |
High | 41 | 26 | 15 | |
miR-4294 | ||||
Low | 41 | 14 | 27 | 0.004 |
High | 41 | 27 | 14 |
HPV detection was performed by Hybrid Capture 2 (HC2) HPV DNA test (Digene).
HPV: human papillomavirus.